Northwestern Mutual Investment Management Company’s Emergent Biosolutions EBS Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,895	Closed	-$395K	–	903
2021 Q3	$395K	Buy	7,895 +309	+4%	+$18.7K	0.01%	840
2021 Q2	$478K	Buy	7,586 +29	+0.4%	+$1.86K	0.01%	807
2021 Q1	$702K	Sell	7,557 -7,932	-51%	-$812K	0.01%	642
2020 Q4	$1.39M	Buy	+15,489	New	+$1.42M	0.02%	486

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northwestern Mutual Investment Management Company's EBS Position: Q4 2021 in Review

Northwestern Mutual Investment Management Company sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 7,895 shares — an estimated $395K sold.

Northwestern Mutual Investment Management Company first reported a position in EBS in Q4 2020 and held it in 4 quarters. The position peaked at $1.39M in Q4 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Northwestern Mutual Investment Management Company reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 7,895 Emergent Biosolutions shares in Q4 2021, an estimated $395K.
Northwestern Mutual Investment Management Company first reported a position in Emergent Biosolutions in Q4 2020 and held it in 4 quarters.
Northwestern Mutual Investment Management Company's Emergent Biosolutions position peaked at $1.39M in Q4 2020.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q4 2021, filed 3 Feb 2022.